Head-To-Head Comparison: DarioHealth (NASDAQ:DRIO) & Doximity (NYSE:DOCS)

DarioHealth (NASDAQ:DRIO) and Doximity (NYSE:DOCS) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, risk, valuation, profitability, analyst recommendations and institutional ownership.

Valuation and Earnings

This table compares DarioHealth and Doximity”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DarioHealth	$21.00 million	2.51	-$41.71 million	($6.13)	-1.17
Doximity	$644.86 million	6.91	$196.05 million	$0.85	29.42

Doximity has higher revenue and earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

33.4% of DarioHealth shares are held by institutional investors. Comparatively, 87.2% of Doximity shares are held by institutional investors. 3.5% of DarioHealth shares are held by company insiders. Comparatively, 31.8% of Doximity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Volatility and Risk

DarioHealth has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500. Comparatively, Doximity has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and target prices for DarioHealth and Doximity, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DarioHealth	1	1	1	0	2.00
Doximity	4	12	7	2	2.28

DarioHealth presently has a consensus target price of $9.00, indicating a potential upside of 25.35%. Doximity has a consensus target price of $32.10, indicating a potential upside of 28.32%. Given Doximity’s stronger consensus rating and higher probable upside, analysts clearly believe Doximity is more favorable than DarioHealth.

Profitability

This table compares DarioHealth and Doximity’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
DarioHealth	-169.87%	-54.81%	-33.36%
Doximity	25.48%	18.06%	15.40%

Summary

Doximity beats DarioHealth on 15 of the 15 factors compared between the two stocks.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

About Doximity

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company’s cloud-based platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical companies and health systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.